VAERS Explorer
Back to explore

Report #2851131

Received Jul 24, 2025

A note on interpretation. VAERS reports are unverified and may be incomplete or coincidental. A report does not establish that a vaccine caused an event, and counts should not be used to calculate incidence or infer causation. Full disclaimer

Overview

Sex
Female
Age
50 yrs
State
MS
Recovered
Not recovered
Vaccinated
Jul 21, 2025
Onset
Jul 23, 2025
Days to onset
2
Hospital days
—

Vaccines (3)

TypeNameManufacturerDoseLotRoute / Site
PNC21PNEUMO (CAPVAXIVE)MERCK & CO. INC.N/A—IM / RA
TDAPTDAP (BOOSTRIX)GLAXOSMITHKLINE BIOLOGICALSN/A—IM / RA
VARZOSZOSTER (SHINGRIX)GLAXOSMITHKLINE BIOLOGICALS1—SC / LA

Symptoms (3)

Injection site erythemaInjection site painInjection site warmth

Symptom narrative

Severe redness below the injection site of the Capvaxive comprising half the circumference of the right arm (approximately 3 ? x 5 ?) in addition to excessive warmth and pain to the affected area. Treated with daily Aleve or Ibuprofen and still unresolved after 72 hours.

Current illness

none

Medical history

HTN, HLD, Anxiety and Depression

Other medications

Benazepril, Sertraline, Eye Omega, and Macular Protect

Allergies

Sulfa?hives

Lab data

none